Doubling survival rates

MULTIPLE MYELOMA: Keeping it under control.

CHEMOTHERAPY and drugs have helped to double survival rates in patients with multiple myeloma, according to the Josep Carreras Leukaemia Foundation.

Multiple myeloma is a cancer arising from plasma cells, a type of white blood cell which is made in the bone marrow. In myeloma, these plasma cells become abnormal, multiply uncontrollably and release only one type of antibody which has no useful function. 

The treatment of multiple myeloma, “has revolutionised over the past 15 years,” said Albert Oriol, haematologist and researcher from Barecelona’s Josep Carreras Leukaemia Foundation. 

More than 2,000 people in Spain are diagnosed with the condition each year with the disease having a higher incidence in those aged over 65.

As there is no complete cure, “today, the goal is to keep this cancer under control and patients as long as possible, free of symptoms,” said Oriol, through a combination of specific drugs and bone marrow transplantation in young patients.

The researcher is working with colleagues in the USA and Canada on new drug combinations to prolong patient’s survival and quality of life. “We’re improving rapidly, and we have learnt a lot already,” said Oriol.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Euro Weekly News Media

Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments


    • Tom

      15 September 2016 • 15:13

      Often cited statistic is that less than 50% survive 5 years. Is there a study doubling that 5 year figure?

      Reply

    Leave a comment

    Your email address will not be published.